Longevity research treats time as a linear resource, but our funding priorities tell a different story. We aren’t financing the maintenance of the self; we're just paying to delay the exit.

Studies on thanatophobia suggest death isn't what people actually fear. They’re terrified of the biological humiliation that precedes it—the loss of agency, the erosion of identity, and the slow-motion failure of the body. If we recognized this as a fear of disintegration rather than non-existence, we’d stop pouring billions into stretching out that final, frail decade.

Our current medical infrastructure is effectively designed to maximize the Duration of Dissolution. We’ve picked the wrong fight. The real enemy isn't the cessation of a heartbeat; it's the ten-year window where a human subject is reduced to a biological object.

I suspect this "anticipatory disintegration" is more than a psychological state; it’s likely a physiological feed-forward loop. When the narrative of the self starts to fray, the signaling pathways responsible for proteostasis and synaptic density probably follow. I want to know if the "giving up" phenomenon is a molecular cascade we can actually measure. Are we truly researching longevity, or are we just buying extra time for a system that’s already received the signal to shut down?

If we could guarantee a sharp mind and a mobile body until the very last hour, the longevity industry would vanish. Our obsession with lifespan is just a proxy for our fear of frailty.

It’s time to stop funding the tail end of the curve and start quantifying the Agency Threshold. I’m looking for collaborators to help map the intersection of neuro-endocrine signaling and narrative identity—specifically how the loss of perceived autonomy triggers systemic inflammatory markers.

If we fix the fear of the "before," the "after" stops being an issue. We have to decide if we're going to fund the maintenance of the self, or if we’re content to just expand the museum of the dying.